Authors: Veronica Kramer, Fernando Yañez, Ivan Godoy, Jorge Jalil, Ramon Corbalan, Carlos Navarrete, Monica Acevedo, Pontificia Universidad Católica de Chile, Santiago, Chile, Universidad de La Serena, La Serena, Chile.


Background: Cardiovascular risk determination has been traditionally supported by scores such as Framingham (FRAM). However, there are subjects in which this prediction may be poor.

Objective: To determine the incremental predictive power of mortality of two non traditional risk factors (RF): aerobic capacity and high sensitivity C-reactive protein (hsCRP) beyond traditional RF in a primary prevention population.

Methods: Prospective study in 3,217 subjects in Santiago, Chile (37% women, mean age = 53±13) without known CHD/CVD, followed in a preventive cardiology unit between 2002 and 2010. All subjects were surveyed about traditional risk factors. We measured: BMI, waist, systolic and diastolic blood pressure (BP), fasting lipids, blood sugar, and 2 non-traditional RF: aerobic capacity determined by METS (through a symptom-limited stress test) and hsCRP. FRAM was calculated for every subject. We assessed all-cause mortality in August 2011, with a median follow up of 6 ± 2 years. We constructed 4 models for mortality risk prediction: FRAM, FRAM+METS, FRAM+logCRP, FRAM+METS+logCRP. For these, ROC curves and C-index were estimated using mortality against non mortality as outcome.

Results: During the follow up there were 50 deaths. The survivors were significantly younger and had lower BP, waist and blood sugar (p<0.01 for all). The deceased subjects had a significantly lower aerobic capacity (8.5 versus 11.6 METS, p<0.0001) and a significantly higher hsCRP (4.5 versus 1.9mg/L, p=0.04). FRAM among the deceased was 11% and among the survivors 7%. FRAM did not predict mortality [C=0.55 (95% IC 0.47-0.64)]. Among the other 3 models, FRAM+METS [C=0.78 (0.69-0.85)] showed the best predictive power without overlapping confidence intervals with FRAM model [C=0.78 (0.69-0.85)]. The other models predicted mortality but not significantly beyond FRAM: FRAM+METS+logPCR [C= 0.83 (0.60-0.93)]; FRAM + logPCR [C= 0.73 (0.51-0.90)].

Conclusion: This study showed that the determination of two non-traditional RF: aerobic capacity and hsCRP, added incremental predictive power of mortality beyond the traditional RF considered in FRAM.

Pontificia Universidad Católica de Chile 2017
Avda. Libertador Bernando O'higgins 340, Santiago, Chile.

¿Cómo llegar?
Mesa central (56) (2) 2354 2000
Politicas de privacidad
Optimizado para: Explorer 10.0, Firefox 52.0, Chrome 58.0, Safari 8.0 o superiores.